Template Description
2wma: STRUCTURAL AND THERMODYNAMIC CONSEQUENCES OF CYCLIZATION OLIGANDS FOR THE RECRUITMENT SITE OF CYCLIN A Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2wmaA
24%
1223-1491
2wmaC
26%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTAPSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT--------
>2wmaC
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR---TLGV----PPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3ppz: CRYSTAL STRUCTURE OF CTR1 KINASE DOMAIN IN COMPLEX WITH ST Solved by: X-RAY, Resolution: 2.99A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1490
3ppzA
27%
>target
----------EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKYG---AFKESVVINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTAPSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLK--HPVFR
>3ppzA
DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILME--------AERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYT-VKVCDFGLSRLKASTF----LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAA---VGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK
[Model]
1230-1490
3ppzB
26%
>target
-------------IGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY---GAFKESVVINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTAPSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLK--HPVFR
>3ppzB
DGDDMDIPWCDLNIKEKIGATVHRAEWH--GSDVAVKILMEQDF----HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYT-VKVCDFGLSRLKASTF----LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAA---VGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK
[Model]
2iw8: STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A F82H-L83V-H84D MUTANT WITH AN O6-CYCLOHEXYLMETHYLGUANINE INHIBITOR Solved by: X-RAY, Resolution: 2.30A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2iw8A
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------A-----------PSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT--------
>2iw8A
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEHVD-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR
[Model]
1223-1491
2iw8C
26%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTAPSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT--------
>2iw8C
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEHVD-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR---TLGV----PPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1oiu: STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 6-CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1491
1oiuA
24%
>target
-----EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------AP-----------SIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT---------
>1oiuA
PGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLT-------EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR
[Model]
1223-1491
1oiuC
26%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTAPSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT--------
>1oiuC
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR---TLGV----PPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3bhu: STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEWITH THE INHIBITOR MERIOLIN 5 Solved by: X-RAY, Resolution: 2.30A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3bhuA
24%
>target
----EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3bhuA
GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLD------TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1223-1492
3bhuC
26%
>target
----EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKYG--AFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTAPSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>3bhuC
GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT----ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRT--LGTFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1ogu: STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 2-ARYLAMINO-4-CYCLOHEXYLMETHYL-5-NITROSO-6- AMINOPYRIMIDINE INHIBITOR Solved by: X-RAY, Resolution: 2.60A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1491
1oguA
24%
>target
-----EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------AP-----------SIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT---------
>1oguA
PGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLT-------EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR
[Model]
1223-1492
1oguC
26%
>target
-----EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKYG--AFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTAPSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>1oguC
PGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT----ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRT--LGTFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1h26: CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P53 Solved by: X-RAY, Resolution: 2.24A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
1h26A
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>1h26A
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1223-1491
1h26C
26%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTAPSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT--------
>1h26C
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT----ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR-----TLGTVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3bht: STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEWITH THE INHIBITOR MERIOLIN 3 Solved by: X-RAY, Resolution: 2.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3bhtA
24%
>target
----EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3bhtA
GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLD------TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1223-1492
3bhtC
26%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTAPSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>3bhtC
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT----ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRT--LGTFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3dog: STRUCTURE OF THR 160 PHOSPHORYLATED CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR N-&-N1 Solved by: X-RAY, Resolution: 2.70A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3dogC
26%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKYG--AFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTAPSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT--------
>3dogC
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR---TL--GTVP-PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR
[Model]
1223-1491
3dogA
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------AP-----------SIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT----------
>3dogA
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLTE-----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1h25: CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM RETINOBLASTOMA-ASSOCIATED PROTEIN Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1491
1h25A
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------A-----------PSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT-----
>1h25A
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT----ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVR----TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV
[Model]
1223-1491
1h25C
26%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASAT---------TAPSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT-----
>1h25C
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT----ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV
[Model]
3bhv: STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEWITH THE INHIBITOR VARIOLIN B Solved by: X-RAY, Resolution: 2.30A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3bhvA
24%
>target
----EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3bhvA
GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLD------TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1223-1492
3bhvC
26%
>target
----EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKYG--AFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTAPSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>3bhvC
GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT----ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRT--LGTFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3qhr: STRUCTURE OF A PCDK2/CYCLINA TRANSITION-STATE MIMIC Solved by: X-RAY, Resolution: 2.17A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1491
3qhrA
25%
>target
----EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSK--YGAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT--------
>3qhrA
GHMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1223-1491
3qhrC
25%
>target
----EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSK--YGAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT--------
>3qhrC
GHMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
4gcj: CDK2 IN COMPLEX WITH INHIBITOR RC-3-89 Solved by: X-RAY, Resolution: 1.42A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1222-1491
4gcjA
25%
>target
-------AEWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSK--YGAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PS-----------IPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT----------
>4gcjA
LGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT----ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVP----VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3qhw: STRUCTURE OF A PCDK2/CYCLINA TRANSITION-STATE MIMIC Solved by: X-RAY, Resolution: 2.17A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1491
3qhwA
25%
>target
----EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSK--YGAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT--------
>3qhwA
GHMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1223-1491
3qhwC
25%
>target
----EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSK--YGAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT--------
>3qhwC
GHMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1oit: IMIDAZOPYRIDINES: A POTENT AND SELECTIVE CLASS OF CYCLIN- DEPENDENT KINASE INHIBITORS IDENTIFIED THROUGH STRUCTURE-BASED HYBRIDISATION Solved by: X-RAY, Resolution: 1.60A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1224-1491
1oitA
24%
>target
-WLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APS-----------IPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT----------
>1oitA
NFQKVEKIGEGTYGVVYKARNK-LGEVVALKKITA---------------IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLAR---------------AVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1okw: CYCLIN A BINDING GROOVE INHIBITOR AC-ARG-ARG-LEU-ASN-(M-CLPHE)-NH2 Solved by: X-RAY, Resolution: 3.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
1okwA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>1okwA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1223-1492
1okwC
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>1okwC
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1ol1: CYCLIN A BINDING GROOVE INHIBITOR H-CIT-CIT-LEU-ILE-(P-F- PHE)-NH2 Solved by: X-RAY, Resolution: 3.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
1ol1A
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>1ol1A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1223-1492
1ol1C
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>1ol1C
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3qql: CDK2 IN COMPLEX WITH INHIBITOR L3 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3qqlA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3qqlA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
4ez3: CDK2 IN COMPLEX WITH NSC 134199 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
4ez3A
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>4ez3A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3f5x: CDK-2-CYCLIN COMPLEX WITH INDAZOLE INHIBITOR 9 BOUND AT ITACTIVE SITE Solved by: X-RAY, Resolution: 2.40A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1491
3f5xA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------A-----------PSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT----------
>3f5xA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP-KRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1223-1492
3f5xC
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------P-----------SIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3f5xC
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3py1: CDK2 TERNARY COMPLEX WITH SU9516 AND ANS Solved by: X-RAY, Resolution: 2.49A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3py1A
24%
>target
------EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSK--YGAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------P-----------SIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3py1A
SPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT----ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2wpa: OPTIMISATION OF 6,6-DIMETHYL PYRROLO 3,4-C PYRAZOLES: IDENTIFICATION OF PHA-793887, A POTENT CDK INHIBITOR SUITABLE FOR INTRAVENOUS DOSING Solved by: X-RAY, Resolution: 2.60A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2wpaA
24%
>target
------EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>2wpaA
PLVDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1223-1492
2wpaC
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------AP-----------SIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>2wpaC
DMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT----ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3r1s: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-127 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3r1sA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3r1sA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3qqh: CDK2 IN COMPLEX WITH INHIBITOR L2-2 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3qqhA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3qqhA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2uzl: CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR Solved by: X-RAY, Resolution: 3.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2uzlA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>2uzlA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1223-1492
2uzlC
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>2uzlC
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3lfn: CRYSTAL STRUCTURE OF CDK2 WITH SAR57, AN AMINOINDAZOLE TYPINHIBITOR Solved by: X-RAY, Resolution: 2.28A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3lfnA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------AP-----------SIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3lfnA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARA-------------HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2uzb: CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR Solved by: X-RAY, Resolution: 3.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2uzbA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>2uzbA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1223-1492
2uzbC
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>2uzbC
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1h1q: STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU6094 Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
1h1qA
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>1h1qA
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1223-1492
1h1qC
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>1h1qC
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3ej1: CDK2/CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR Solved by: X-RAY, Resolution: 3.22A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1491
3ej1A
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APSI-----------PSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT----------
>3ej1A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLT-------EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1223-1491
3ej1C
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSK--YGAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------AP-----------SIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT---------
>3ej1C
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLT-------EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR
[Model]
3rkb: CDK2 IN COMPLEX WITH INHIBITOR RC-2-73 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3rkbA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3rkbA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3rk9: CDK2 IN COMPLEX WITH INHIBITOR RC-2-74 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3rk9A
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3rk9A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2vth: IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6- DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519),A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. Solved by: X-RAY, Resolution: 2.0A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1491
2vthA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APSI-----------PSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT----------
>2vthA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRS-------------TAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLAR---------------AFVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1f5q: CRYSTAL STRUCTURE OF MURINE GAMMA HERPESVIRUS CYCLIN COMPLEXED TO HUMAN CYCLIN DEPENDENT KINASE 2 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1228-1493
1f5qA
24%
>target
-----QQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------AP-----------SIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTTW--------
>1f5qA
MENFQKVEKEGTYGVVYKARNKLTGEVVALKKIRLDT----ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1228-1492
1f5qC
24%
>target
-----QQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APSI-------PSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT--------
>1f5qC
MENFQKVEKEGTYGVVYKAR---NGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR
[Model]
3sqq: CDK2 IN COMPLEX WITH INHIBITOR RC-3-96 Solved by: X-RAY, Resolution: 1.85A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1491
3sqqA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------AP-----------SIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT----------
>3sqqA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARRTY----------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2vv9: CDK2 IN COMPLEX WITH AN IMIDAZOLE PIPERAZINE Solved by: X-RAY, Resolution: 1.9A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1491
2vv9A
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT----------
>2vv9A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLV----------PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLA-----------------VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3pxq: CDK2 IN COMPLEX WITH 3 MOLECULES OF 8-ANILINO-1-NAPHTHALEN Solved by: X-RAY, Resolution: 1.90A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3pxqA
24%
>target
------EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------AP-----------SIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3pxqA
SPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3my5: CDK2/CYCLINA IN COMPLEX WITH DRB Solved by: X-RAY, Resolution: 2.10A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1491
3my5A
24%
>target
----EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA------------------------PSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT----------
>3my5A
GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLT-------EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1223-1491
3my5C
26%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTAPSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT--------
>3my5C
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRT---L---GVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3s1h: CDK2 IN COMPLEX WITH INHIBITOR RC-2-39 Solved by: X-RAY, Resolution: 1.90A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1491
3s1hA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APS-----------IPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT----------
>3s1hA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRP------------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLA-----------------VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3ql8: CDK2 IN COMPLEX WITH INHIBITOR JWS-6-260 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3ql8A
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3ql8A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1h24: CDK2/CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT PEPTIDE FROM E2F Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1491
1h24A
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------A-----------PSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT-----
>1h24A
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT----ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVR----TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV
[Model]
1223-1491
1h24C
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------A-----------PSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT-----
>1h24C
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT----ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVR----TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV
[Model]
2r3f: CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2r3fA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSK--YGAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APSI-----------PSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>2r3fA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIVP------------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3tiy: CDK2 IN COMPLEX WITH NSC 35676 Solved by: X-RAY, Resolution: 2.02A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1491
3tiyA
24%
>target
-EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------AP-----------SIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT----------
>3tiyA
ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1b39: HUMAN CYCLIN-DEPENDENT KINASE 2 PHOSPHORYLATED ON THR 160 Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
1b39A
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSK--YGAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APSI-----------PSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>1b39A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIVP------------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1gy3: PCDK2/CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE SUBSTRATE Solved by: X-RAY, Resolution: 2.70A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
1gy3A
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>1gy3A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1223-1491
1gy3C
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT--------
>1gy3C
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVP-----VRTYHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3qzf: CDK2 IN COMPLEX WITH INHIBITOR JWS-6-52 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3qzfA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3qzfA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1w98: THE STRUCTURAL BASIS OF CDK2 ACTIVATION BY CYCLIN E Solved by: X-RAY, Resolution: 2.70A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
1w98A
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA------------------------PSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT--------
>1w98A
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT----ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR
[Model]
1e1v: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR NU2058 Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
1e1vA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSK--YGAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APSI-----------PSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>1e1vA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIVP------------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3qzh: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-124 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3qzhA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3qzhA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3unj: CDK2 IN COMPLEX WITH INHIBITOR YL1-038-31 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3unjA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3unjA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
4bbm: CRYSTAL STRUCTURE OF THE HUMAN CDKL2 KINASE DOMAIN WITH BOUND TCS 2312 Solved by: X-RAY, Resolution: 2.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1228-1491
4bbmA
25%
>target
------------QQIGL-GAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKYGAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-----------------PS---------IPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT-------------------
>4bbmA
TENLYFQSMEKYENLGLVGSYGMVMKCRNKDTGRIVAIKKFLESDD----DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGV-VKLCDFGFARTLAAPG----EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAERFSQELQLKVQKDA
[Model]
1228-1491
4bbmB
24%
>target
------QQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKYGAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-----------------------A---PSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT-------------------
>4bbmB
YFQSMEKYENLGSYGMVMKCRNKDTGRIVAIKKFKK-------------IAMREIKLLKQLRHENLVNLLEV------CYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGV-VKLCDFGFARTLAAPG----EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAERFSQELQLKVQKDA
[Model]
1okv: CYCLIN A BINDING GROOVE INHIBITOR H-ARG-ARG-LEU-ILE-PHE-NH Solved by: X-RAY, Resolution: 2.40A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1491
1okvA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA------------------------PSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT------
>1okvA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVR----TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP
[Model]
1223-1491
1okvC
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA------------------------PSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT--------
>1okvC
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
2a0c: HUMAN CDK2 IN COMPLEX WITH OLOMOUCINE II, A NOVEL 2,6,9- TRISUBSTITUTED PURINE CYCLIN-DEPENDENT KINASE INHIBITOR Solved by: X-RAY, Resolution: 1.95A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2a0cX
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APS-----------IPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT--------
>2a0cX
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR
[Model]
3pxy: CDK2 IN COMPLEX WITH INHIBITOR JWS648 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3pxyA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3pxyA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3r9h: CDK2 IN COMPLEX WITH INHIBITOR RC-2-142 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3r9hA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3r9hA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1oi9: STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 6-CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR Solved by: X-RAY, Resolution: 2.10A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1491
1oi9A
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------AP-----------SIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT--------
>1oi9A
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLTE-----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1223-1492
1oi9C
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>1oi9C
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3qrt: CDK2 IN COMPLEX WITH INHIBITOR NSK-MC2-55 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3qrtA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3qrtA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2ds1: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4 INHIBITOR Solved by: X-RAY, Resolution: 2.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2ds1A
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSK--YGAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APS-----------IPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>2ds1A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIVP------------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEHVH-QDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3qu0: CDK2 IN COMPLEX WITH INHIBITOR RC-2-38 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3qu0A
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3qu0A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3rjc: CDK2 IN COMPLEX WITH INHIBITOR L4-12 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3rjcA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3rjcA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2r3o: CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR Solved by: X-RAY, Resolution: 1.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2r3oA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APSI-----------PSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>2r3oA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIVP------------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1pkd: THE CRYSTAL STRUCTURE OF UCN-01 IN COMPLEX WITH PHOSPHO- CDK2/CYCLIN A Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
1pkdA
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>1pkdA
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1223-1492
1pkdC
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>1pkdC
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
2c6m: CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR Solved by: X-RAY, Resolution: 2.30A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2c6mA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------P-----------SIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>2c6mA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLV----------PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
2wih: STRUCTURE OF CDK2-CYCLIN A WITH PHA-848125 Solved by: X-RAY, Resolution: 2.60A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2wihA
24%
>target
------EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>2wihA
PLVDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1223-1492
2wihC
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------AP-----------SIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>2wihC
DMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT----ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3qwj: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-142 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3qwjA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3qwjA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3fz1: CRYSTAL STRUCTURE OF A BENZTHIOPHENE INHIBITOR BOUND TO HUMAN CYCLIN-DEPENDENT KINASE-2 (CDK-2) Solved by: X-RAY, Resolution: 1.90A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3fz1A
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3fz1A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRVP-----------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFG-----------HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2c6i: CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR Solved by: X-RAY, Resolution: 2.20A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2c6iA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>2c6iA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLV----------PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2wmb: STRUCTURAL AND THERMODYNAMIC CONSEQUENCES OF CYCLIZATION OLIGANDS FOR THE RECRUITMENT SITE OF CYCLIN A Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2wmbA
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>2wmbA
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1223-1491
2wmbC
26%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTAPSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT--------
>2wmbC
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT----ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR------TLKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3r7y: CDK2 IN COMPLEX WITH INHIBITOR KVR-2-88 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3r7yA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3r7yA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1pxj: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YLAMI Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
1pxjA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>1pxjA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3lfs: CRYSTAL STRUCTURE OF CDK2 WITH SAR37, AN AMINOINDAZOLE TYPINHIBITOR Solved by: X-RAY, Resolution: 2.40A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3lfsA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSK--YGAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APS-----------IPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3lfsA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRP------------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2whb: TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2,CYCLIN A THROUGH STRUCTURE GUIDED DESIGN Solved by: X-RAY, Resolution: 3.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2whbA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>2whbA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1223-1492
2whbC
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>2whbC
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3r7e: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-67 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3r7eA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3r7eA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3rpv: CDK2 IN COMPLEX WITH INHIBITOR RC-2-88 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3rpvA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3rpvA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3qqg: CDK2 IN COMPLEX WITH INHIBITOR L2-5 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3qqgA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3qqgA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1hcl: HUMAN CYCLIN-DEPENDENT KINASE 2 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
1hclA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>1hclA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2c68: CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR Solved by: X-RAY, Resolution: 2.30A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2c68A
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------P-----------SIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>2c68A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLV----------PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1h1s: STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU6102 Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
1h1sA
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>1h1sA
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1223-1492
1h1sC
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>1h1sC
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3qxo: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-84 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3qxoA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3qxoA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1ol2: CYCLIN A BINDING GROOVE INHIBITOR H-ARG-ARG-LEU-ASN-(P-F- PHE)-NH2 Solved by: X-RAY, Resolution: 3.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
1ol2A
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>1ol2A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1223-1492
1ol2C
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>1ol2C
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3r71: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-162 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3r71A
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3r71A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3qtx: CDK2 IN COMPLEX WITH INHIBITOR RC-2-35 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3qtxA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3qtxA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2v22: REPLACE: A STRATEGY FOR ITERATIVE DESIGN OF CYCLIN BINDINGGROOVE INHIBITORS Solved by: X-RAY, Resolution: 3.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2v22C
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>2v22C
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1223-1492
2v22A
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>2v22A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
2bpm: STRUCTURE OF CDK2-CYCLIN A WITH PHA-630529 Solved by: X-RAY, Resolution: 2.60A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2bpmA
24%
>target
------EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>2bpmA
PLVDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1223-1492
2bpmC
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------AP-----------SIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>2bpmC
DMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT----ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3ddp: STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEWITH THE INHIBITOR CR8 Solved by: X-RAY, Resolution: 2.70A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3ddpC
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3ddpC
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT----ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1223-1492
3ddpA
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA------------------------PSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT--------
>3ddpA
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT----ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR
[Model]
2r3r: CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2r3rA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSK--YGAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APSI-----------PSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>2r3rA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIVP------------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3s0o: CDK2 IN COMPLEX WITH INHIBITOR RC-1-138 Solved by: X-RAY, Resolution: 2.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1491
3s0oA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSI-----------PSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT----------
>3s0oA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLT-------EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFARAFGVPV------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2wev: TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2,CYCLIN A THROUGH STRUCTURE GUIDED DESIGN Solved by: X-RAY, Resolution: 2.53A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1491
2wevA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------A-----------PSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT-------
>2wevA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH
[Model]
1223-1492
2wevC
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>2wevC
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3r8v: CDK2 IN COMPLEX WITH INHIBITOR RC-1-135 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3r8vA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3r8vA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1ykr: CRYSTAL STRUCTURE OF CDK2 WITH AN AMINOIMIDAZO PYRIDINE INHIBITOR Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
1ykrA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------P-----------SIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>1ykrA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2uzo: CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR Solved by: X-RAY, Resolution: 2.30A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2uzoA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------P-----------SIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>2uzoA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLV----------PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
2vta: IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6- DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519),A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. Solved by: X-RAY, Resolution: 2.0A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1491
2vtaA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APSI-----------PSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT----------
>2vtaA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRS-------------TAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLAR---------------AFVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1h07: CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6-BIS ANILINO PYRIMIDINE CDK4 INHIBITOR Solved by: X-RAY, Resolution: 1.85A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
1h07A
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSK--YGAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APS-----------IPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>1h07A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRVP-----------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARPVRT--------YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3rk5: CDK2 IN COMPLEX WITH INHIBITOR RC-2-72 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3rk5A
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3rk5A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1h1r: STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU6086 Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
1h1rA
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>1h1rA
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1223-1492
1h1rC
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>1h1rC
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3r6x: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-158 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3r6xA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3r6xA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1w8c: CO-CRYSTAL STRUCTURE OF 6-CYCLOHEXYLMETHOXY-8-ISOPROPYL-9HPURIN-2-YLAMINE AND MONOMERIC CDK2 Solved by: X-RAY, Resolution: 2.05A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
1w8cA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APSI-----------PSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>1w8cA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRVP-----------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2g9x: STRUCTURE OF THR 160 PHOSPHORYLATED CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR NU6271 Solved by: X-RAY, Resolution: 2.70A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2g9xA
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>2g9xA
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT----ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1223-1492
2g9xC
26%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSK--YGAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTAPSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>2g9xC
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2x1n: TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2,CYCLIN A THROUGH STRUCTURE GUIDED DESIGN Solved by: X-RAY, Resolution: 3.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2x1nC
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>2x1nC
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1223-1492
2x1nA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>2x1nA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1gz8: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 2-AMINO-6-(3'-METHYL-2'-OXO)BUTOXYPURINE Solved by: X-RAY, Resolution: 2.05A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
1gz8A
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APSI-----------PSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>1gz8A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRVP-----------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3roy: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-154 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3royA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3royA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
4bco: STRUCTURE OF CDK2 IN COMPLEX WITH CYCLIN A AND A 2-AMINO-4HETEROARYL-PYRIMIDINE INHIBITOR Solved by: X-RAY, Resolution: 2.70A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1491
4bcoC
26%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTAPSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT--------
>4bcoC
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRT---LGTSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1223-1492
4bcoA
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>4bcoA
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT----ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3rpo: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-156 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3rpoA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3rpoA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2c5o: DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN Solved by: X-RAY, Resolution: 2.53A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1491
2c5oA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------A-----------PSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT-------
>2c5oA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH
[Model]
1223-1492
2c5oC
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>2c5oC
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3ti1: CDK2 IN COMPLEX WITH SUNITINIB Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3ti1A
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3ti1A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1jst: PHOSPHORYLATED CYCLIN-DEPENDENT KINASE-2 BOUND TO CYCLIN A Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
1jstA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------P-----------SIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>1jstA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1223-1492
1jstC
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------P-----------SIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>1jstC
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3py0: CDK2 IN COMPLEX WITH INHIBITOR SU9516 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3py0A
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3py0A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3rai: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-160 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3raiA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3raiA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2cch: THE CRYSTAL STRUCTURE OF CDK2 CYCLIN A IN COMPLEX WITH A SUBSTRATE PEPTIDE DERIVED FROM CDC MODIFIED WITH A GAMMA-LINKED ATP ANALOGUE Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2cchA
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>2cchA
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1223-1492
2cchC
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>2cchC
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1pxp: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YLN',N'-DIMETHYL-BENZENE-1,4-DIAMINE Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
1pxpA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>1pxpA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2r3k: CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR Solved by: X-RAY, Resolution: 1.70A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2r3kA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSK--YGAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APSI-----------PSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>2r3kA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIVP------------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLAR----------------VVTLWYRAPEILLGKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2c5v: DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN Solved by: X-RAY, Resolution: 3.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2c5vA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>2c5vA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1223-1492
2c5vC
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>2c5vC
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
2i40: CDK2/CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE INHIBITOR Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2i40A
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA------------------------PSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT--------
>2i40A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLT-------EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGV-------PVRTYVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR
[Model]
1223-1492
2i40C
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>2i40C
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1fq1: CRYSTAL STRUCTURE OF KINASE ASSOCIATED PHOSPHATASE (KAP) ICOMPLEX WITH PHOSPHO-CDK2 Solved by: X-RAY, Resolution: 3.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
1fq1B
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>1fq1B
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3r7v: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-9 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3r7vA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3r7vA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1fvv: THE STRUCTURE OF CDK2/CYCLIN A IN COMPLEX WITH AN OXINDOLEINHIBITOR Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
1fvvA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------P-----------SIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>1fvvA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1223-1492
1fvvC
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------P-----------SIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>1fvvC
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2b54: HUMAN CYCLIN DEPENDENT KINASE 2 (CKD2)COMPLEXED WITH DIN- 232305 Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2b54A
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------P-----------SIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>2b54A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3r8m: CDK2 IN COMPLEX WITH INHIBITOR L3-3 Solved by: X-RAY, Resolution: 1.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1491
3r8mA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSK--YGAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------P-----------SIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT----------
>3r8mA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAF------------GEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2wxv: STRUCTURE OF CDK2-CYCLIN A WITH A PYRAZOLO(4,3-H) QUINAZOLINE-3-CARBOXAMIDE INHIBITOR Solved by: X-RAY, Resolution: 2.60A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2wxvC
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------AP-----------SIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>2wxvC
DMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT----ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1223-1492
2wxvA
24%
>target
------EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>2wxvA
PLVDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1oiy: STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 6-CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR Solved by: X-RAY, Resolution: 2.40A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1491
1oiyA
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------AP-----------SIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT--------
>1oiyA
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLT-------EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1223-1492
1oiyC
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>1oiyC
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3ral: CDK2 IN COMPLEX WITH INHIBITOR RC-2-34 Solved by: X-RAY, Resolution: 1.90A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1491
3ralA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APS-----------IPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT----------
>3ralA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRP------------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLA-----------------VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3qzg: CDK2 IN COMPLEX WITH INHIBITOR JWS-6-76 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3qzgA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3qzgA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2wfy: TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2,CYCLIN A THROUGH STRUCTURE GUIDED DESIGN Solved by: X-RAY, Resolution: 2.53A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1491
2wfyA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------A-----------PSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT-------
>2wfyA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH
[Model]
1223-1492
2wfyC
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>2wfyC
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1y8y: CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A PYRAZOLO[5-A]PYRIMIDINE INHIBITOR Solved by: X-RAY, Resolution: 2.20A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
1y8yA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>1y8yA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLV----------PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1fin: CYCLIN A-CYCLIN-DEPENDENT KINASE 2 COMPLEX Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
1finA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------P-----------SIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>1finA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1223-1492
1finC
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------P-----------SIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>1finC
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2uzn: CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR Solved by: X-RAY, Resolution: 2.30A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2uznA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APS-----------IPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>2uznA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIPS-------------TAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLAR--------------AFVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1buh: CRYSTAL STRUCTURE OF THE HUMAN CDK2 KINASE COMPLEX WITH CELL CYCLE-REGULATORY PROTEIN CKSHS1 Solved by: X-RAY, Resolution: 2.60A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1491
1buhA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APS-----------IPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT------
>1buhA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLD-----------TTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP
[Model]
3qwk: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-150 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3qwkA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3qwkA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2cci: CRYSTAL STRUCTURE OF PHOSPHO-CDK2 CYCLIN A IN COMPLEX WITHA PEPTIDE CONTAINING BOTH THE SUBSTRATE AND RECRUITMENT SITES OF CDC6 Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2cciA
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>2cciA
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1223-1492
2cciC
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>2cciC
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3r8z: CDK2 IN COMPLEX WITH INHIBITOR RC-1-136 Solved by: X-RAY, Resolution: 1.85A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3r8zA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APS-----------IPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3r8zA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGV--------PTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1h28: CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P107 Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
1h28A
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>1h28A
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1223-1492
1h28C
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>1h28C
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
2b53: HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH DIN-234325 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2b53A
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>2b53A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3p86: CRYSTAL STRUCTURE OF CTR1 KINASE DOMAIN MUTANT D676N IN COSTAUROSPORINE Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1490
3p86A
25%
>target
------EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKYG---AFKESVVINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTAPSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLK--HPVFR
>3p86A
MDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF----HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYT-VKVCDFGTP---------------------EWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV---GFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK
[Model]
1223-1490
3p86B
24%
>target
-------EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY---GAFKESVVINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTAPSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLK--HPVFR
>3p86B
DMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKIL----------------FLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYT-VKVCDFG---------------------TPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAA---VGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK
[Model]
3pj8: STRUCTURE OF CDK2 IN COMPLEX WITH A PYRAZOLO[4,3-D]PYRIMIDBIOISOSTERE OF ROSCOVITINE. Solved by: X-RAY, Resolution: 1.96A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1491
3pj8A
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PS-----------IPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT----------
>3pj8A
GMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRET-------EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAF------------GVVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3qxp: CDK2 IN COMPLEX WITH INHIBITOR RC-3-89 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3qxpA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3qxpA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1pxn: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 4-[4-(4-METHYL-2-METHYLAMINO-THIAZOL-5-YL)- PYRIMIDIN-2-YLAMINO]-PHENOL Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
1pxnA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>1pxnA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1b38: HUMAN CYCLIN-DEPENDENT KINASE 2 Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
1b38A
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSK--YGAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APSI-----------PSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>1b38A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIVP------------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2b52: HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH DPH-042562 Solved by: X-RAY, Resolution: 1.88A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2b52A
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKYG--AFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------AP-----------SIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>2b52A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLAHE---------------VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2c5y: DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN Solved by: X-RAY, Resolution: 2.25A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2c5yA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSK--YGAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APSI-----------PSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT--------
>2c5yA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIGVP-----------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR
[Model]
3qqf: CDK2 IN COMPLEX WITH INHIBITOR L1 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3qqfA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3qqfA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2xnb: DISCOVERY AND CHARACTERISATION OF 2-ANILINO-4-(THIAZOL-5-YPYRIMIDINE TRANSCRIPTIONAL CDK INHIBITORS AS ANTICANCER AGENTS Solved by: X-RAY, Resolution: 1.85A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2xnbA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------AP-----------SIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>2xnbA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLD------TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3r1q: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-102 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3r1qA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3r1qA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2r3g: CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR Solved by: X-RAY, Resolution: 1.96A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2r3gA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------AP-----------SIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>2r3gA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKITA---------------IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2vtj: IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6- DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519),A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. Solved by: X-RAY, Resolution: 2.2A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1491
2vtjA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APSI-----------PSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT----------
>2vtjA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRS-------------TAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLAR-----------------VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1vyw: STRUCTURE OF CDK2/CYCLIN A WITH PNU-292137 Solved by: X-RAY, Resolution: 2.60A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
1vywA
24%
>target
------EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>1vywA
PLVDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1223-1492
1vywC
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------AP-----------SIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>1vywC
DMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT----ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2a4l: HUMAN CYCLIN-DEPENDENT KINASE 2 IN COMPLEX WITH ROSCOVITIN Solved by: X-RAY, Resolution: 2.40A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1491
2a4lA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APS-----------IPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT----------
>2a4lA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIA----------------IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3qqj: CDK2 IN COMPLEX WITH INHIBITOR L2 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3qqjA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3qqjA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3pxf: CDK2 IN COMPLEX WITH TWO MOLECULES OF 8-ANILINO-1-NAPHTHALSULFONATE Solved by: X-RAY, Resolution: 2.49A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3pxfA
24%
>target
------EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSK--YGAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------P-----------SIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3pxfA
SPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT----ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3igg: NOVEL CDK-5 INHIBITORS - CRYSTAL STRUCTURE OF INHIBITOR EFWITH CDK-2 Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3iggA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSK--YGAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APSI-----------PSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3iggA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIVP------------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3r9d: CDK2 IN COMPLEX WITH INHIBITOR RC-2-135 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3r9dA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3r9dA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2w06: STRUCTURE OF CDK2 IN COMPLEX WITH AN IMIDAZOLYL PYRIMIDINECOMPOUND 5C Solved by: X-RAY, Resolution: 2.04A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2w06A
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>2w06A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRVP-----------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAF-------------EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2jgz: CRYSTAL STRUCTURE OF PHOSPHO-CDK2 IN COMPLEX WITH CYCLIN B Solved by: X-RAY, Resolution: 2.90A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1491
2jgzA
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT
>2jgzA
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVR----TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD
[Model]
1urc: CYCLIN A BINDING GROOVE INHIBITOR ACE-ARG-LYS-LEU-PHE-GLY Solved by: X-RAY, Resolution: 3.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
1urcA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>1urcA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1223-1492
1urcC
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>1urcC
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3pxz: CDK2 TERNARY COMPLEX WITH JWS648 AND ANS Solved by: X-RAY, Resolution: 2.49A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3pxzA
24%
>target
------EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSK--YGAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------P-----------SIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3pxzA
SPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT----ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3rk7: CDK2 IN COMPLEX WITH INHIBITOR RC-2-71 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3rk7A
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3rk7A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1pxk: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)PYRIMIDIN-2-YL]N'-HYDROXYIMINOFORMAMIDE Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
1pxkA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSK--YGAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APSI-----------PSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>1pxkA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIVP------------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3r1y: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-134 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3r1yA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3r1yA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2c6o: CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR Solved by: X-RAY, Resolution: 2.30A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2c6oA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------P-----------SIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>2c6oA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLV----------PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3eoc: CDK2/CYCLINA COMPLEXED WITH A IMIDAZO TRIAZIN-2-AMINE Solved by: X-RAY, Resolution: 3.22A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1491
3eocA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APSI-----------PSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT----------
>3eocA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLT-------EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1223-1491
3eocC
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------AP-----------SIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT--------
>3eocC
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLT-------EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1qmz: PHOSPHORYLATED CDK2-CYCLYIN A-SUBSTRATE PEPTIDE COMPLEX Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
1qmzA
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>1qmzA
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1223-1492
1qmzC
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>1qmzC
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1hck: HUMAN CYCLIN-DEPENDENT KINASE 2 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
1hckA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>1hckA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3r8l: CDK2 IN COMPLEX WITH INHIBITOR L3-4 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3r8lA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3r8lA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1jsv: THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) IN COMPLEX WITH 4-[(6-AMINO-4-PYRIMIDINYL) AMINO]BENZENESULFONAMIDE Solved by: X-RAY, Resolution: 1.96A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
1jsvA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------AP-----------SIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>1jsvA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKITA---------------IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
4i3z: STRUCTURE OF PCDK2/CYCLINA BOUND TO ADP AND 2 MAGNESIUM IO Solved by: X-RAY, Resolution: 3.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
4i3zA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>4i3zA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1223-1492
4i3zC
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>4i3zC
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
2xmy: DISCOVERY AND CHARACTERISATION OF 2-ANILINO-4-(THIAZOL-5-YPYRIMIDINE TRANSCRIPTIONAL CDK INHIBITORS AS ANTICANCER AGENTS Solved by: X-RAY, Resolution: 1.90A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2xmyA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>2xmyA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3rak: CDK2 IN COMPLEX WITH INHIBITOR RC-2-32 Solved by: X-RAY, Resolution: 1.90A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1491
3rakA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APS-----------IPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT----------
>3rakA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRP------------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLA-----------------VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1vyz: STRUCTURE OF CDK2 COMPLEXED WITH PNU-181227 Solved by: X-RAY, Resolution: 2.21A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
1vyzA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------AP-----------SIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>1vyzA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKITA---------------IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFG------------EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2vtl: IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6- DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519),A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2vtlA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSK--YGAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APSI-----------PSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>2vtlA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIVP------------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1gii: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4 INHIBITOR Solved by: X-RAY, Resolution: 2.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
1giiA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>1giiA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIVP------------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEHVH-QDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLAR---------------AFVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1pxo: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR [4-(2-AMINO-4-METHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-(3-NITRO-PHENYL)-AMINE Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
1pxoA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>1pxoA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2iw6: STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR Solved by: X-RAY, Resolution: 2.30A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1491
2iw6A
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSK--YGAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------AP-----------SIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT-------
>2iw6A
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLT-------EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH
[Model]
1223-1491
2iw6C
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSK--YGAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------AP-----------SIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT-------
>2iw6C
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVR----TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH
[Model]
3r8p: CDK2 IN COMPLEX WITH INHIBITOR NSK-MC1-6 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3r8pA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3r8pA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1pf8: CRYSTAL STRUCTURE OF HUMAN CYCLIN-DEPENDENT KINASE 2 COMPLEXED WITH A NUCLEOSIDE INHIBITOR Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
1pf8A
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------P-----------SIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>1pf8A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1pxi: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 4-(2,5-DICHLORO-THIOPHEN-3-YL)-PYRIMIDIN-2- YLAMINE Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
1pxiA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>1pxiA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2uue: REPLACE: A STRATEGY FOR ITERATIVE DESIGN OF CYCLIN BINDINGGROOVE INHIBITORS Solved by: X-RAY, Resolution: 3.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2uueA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>2uueA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1223-1492
2uueC
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>2uueC
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3qtw: CDK2 IN COMPLEX WITH INHIBITOR RC-2-13 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3qtwA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3qtwA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3rm6: CDK2 IN COMPLEX WITH INHIBITOR KVR-2-80 Solved by: X-RAY, Resolution: 1.60A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1491
3rm6A
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APSI-----------PSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT----------
>3rm6A
MENFQKVEKIGEGT-GVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3tnw: STRUCTURE OF CDK2/CYCLIN A IN COMPLEX WITH CAN508 Solved by: X-RAY, Resolution: 2.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1491
3tnwA
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APS-----------IPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT----------
>3tnwA
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLT-------EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1223-1491
3tnwC
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA------------------------PSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT------
>3tnwC
MENFQKVEKIGEG--GVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP
[Model]
3rni: CDK2 IN COMPLEX WITH INHIBITOR RC-3-86 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3rniA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3rniA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1pxm: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 3-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2- YLAMINO]-PHENOL Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
1pxmA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSK--YGAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APSI-----------PSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>1pxmA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIVP------------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1e1x: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR NU6027 Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
1e1xA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSK--YGAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APSI-----------PSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>1e1xA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIVP------------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3qtq: CDK2 IN COMPLEX WITH INHIBITOR RC-1-137 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3qtqA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3qtqA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3r28: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-140 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3r28A
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3r28A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2c69: CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR Solved by: X-RAY, Resolution: 2.20A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2c69A
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>2c69A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLV----------PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2clx: 4-ARYLAZO-3,5-DIAMINO-1H-PYRAZOLE CDK INHIBITORS: SAR STUDCRYSTAL STRUCTURE IN COMPLEX WITH CDK2, SELECTIVITY, AND CELLULAR EFFECTS Solved by: X-RAY, Resolution: 1.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2clxA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APSI-----------PSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>2clxA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLG---------VPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVR----TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1p5e: THE STRUCURE OF PHOSPHO-CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR 4,5,6,7-TETRABROMOBENZOTRIAZOLE (TBS) Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
1p5eA
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>1p5eA
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1223-1492
1p5eC
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>1p5eC
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
2exm: HUMAN CDK2 IN COMPLEX WITH ISOPENTENYLADENINE Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2exmA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------P-----------SIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>2exmA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3qtu: CDK2 IN COMPLEX WITH INHIBITOR RC-2-132 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3qtuA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3qtuA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3qx2: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-190 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3qx2A
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3qx2A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3r8u: CDK2 IN COMPLEX WITH INHIBITOR RC-1-132 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3r8uA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3r8uA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3s00: CDK2 IN COMPLEX WITH INHIBITOR L4-14 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3s00A
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3s00A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3qru: CDK2 IN COMPLEX WITH INHIBITOR NSK-MC1-12 Solved by: X-RAY, Resolution: 3.22A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1491
3qruA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APSI-----------PSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT----------
>3qruA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLT-------EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2r3i: CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR Solved by: X-RAY, Resolution: 1.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2r3iA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APSI-----------PSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>2r3iA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIVP------------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2uze: CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR Solved by: X-RAY, Resolution: 3.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2uzeA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>2uzeA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1223-1492
2uzeC
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>2uzeC
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1h1p: STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU2058 Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
1h1pA
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>1h1pA
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1223-1492
1h1pC
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>1h1pC
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3sw4: CRYSTAL STRUCTURE OF THE CDK2 IN COMPLEX WITH THIAZOLYLPYRINHIBITOR Solved by: X-RAY, Resolution: 1.70A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1491
3sw4A
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APSI-----------PSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT----------
>3sw4A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIPS-------------TAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLAR--------------AFGVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3tiz: CDK2 IN COMPLEX WITH NSC 111848 Solved by: X-RAY, Resolution: 2.02A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1491
3tizA
24%
>target
-EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------AP-----------SIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRT----------
>3tizA
ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3r83: CDK2 IN COMPLEX WITH INHIBITOR KVR-2-92 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3r83A
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3r83A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3qtz: CDK2 IN COMPLEX WITH INHIBITOR RC-2-36 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3qtzA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3qtzA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1h27: CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P27 Solved by: X-RAY, Resolution: 2.20A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
1h27A
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>1h27A
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1223-1492
1h27C
24%
>target
---EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>1h27C
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3qqk: CDK2 IN COMPLEX WITH INHIBITOR L4 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3qqkA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3qqkA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2c5n: DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN Solved by: X-RAY, Resolution: 3.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2c5nA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>2c5nA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1223-1492
2c5nC
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>2c5nC
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3r73: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-164 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
3r73A
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>3r73A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTE--------GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2c6t: CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR Solved by: X-RAY, Resolution: 3.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2c6tA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>2c6tA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1223-1492
2c6tC
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>2c6tC
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
2v0d: CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR Solved by: X-RAY, Resolution: 2.20A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2v0dA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRG-QQYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APSIP-----------SHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>2v0dA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLV----------PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
4ez7: CDK2 IN COMPLEX WITH STAUROSPORINE AND 2 MOLECULES OF 8-ANNAPHTHALENE SULFONIC ACID Solved by: X-RAY, Resolution: 2.49A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
4ez7A
24%
>target
------EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSK--YGAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------P-----------SIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>4ez7A
SPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT----ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1pxl: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR [4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-(4-TRIFLUOROMETHYL-PHENYL)-AMINE Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
1pxlA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSK--YGAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APSI-----------PSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>1pxlA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIVP------------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1h08: CDK2 IN COMPLEX WITH A DISUBSTITUTED 2, 4-BIS ANILINO PYRIMIDINE CDK4 INHIBITOR Solved by: X-RAY, Resolution: 1.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
1h08A
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATTA-------------PS-----------IPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>1h08A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIVP------------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFG-----------HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2uzd: CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR Solved by: X-RAY, Resolution: 3.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2uzdA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>2uzdA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1223-1492
2uzdC
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>2uzdC
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
2vtr: IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6- DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519),A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. Solved by: X-RAY, Resolution: 2.40A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2vtrA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSK--YGAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT-------------APS-----------IPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT---------
>2vtrA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRP------------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2c5x: DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN Solved by: X-RAY, Resolution: 3.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1223-1492
2c5xA
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>2c5xA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1223-1492
2c5xC
24%
>target
--EWLKGQQIGLGAFSSCYQAQDVGTGTLMAVKQVTYVRNTSSEQEEVVEALREEIRMMGHLNHPNIIRMLGATCEKSNYNLFIEWMAGGSVAHLLSKY--GAFKESVVINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLASKGTGAGEFQGQLLGTIAFMAPEVLRGQ-QYGRSCDVWSVGCAIIEMACAKPPWNAEKHSNHLALIFKIASATT------------------------APSIPSHLSPGLRDVAVRCLELQPQDRPPSRELLKHPVFRTT-------
>2c5xC
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1jsu: P27(KIP1)/CYCLIN A/CDK2 COMPLEX Solved by: X-RAY, Resolution: 2.30A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]